Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Connie Sommers, Ph.D.

Program Director
Developmental Therapeutics Program
ImmunoOncology Branch
301-215-0532
|
sommersc@mail.nih.gov

Dr. Connie Sommers obtained her Ph.D. in anatomy and cell biology from the Georgetown University School of Medicine. She pioneered the concept of EMT (epithelial-mesenchymal transition) in breast cancer during her time at the NCI Medicine Branch and at Georgetown University. She transitioned to studying developmental immunology in 1994 at NICHD and was a Staff Scientist at NCI for 17 years as an expert on genetic mouse modeling to study T cell signaling. Dr. Sommers joined the IOB in 2017, where she uses her backgrounds in cancer research and in basic immunology. Her programmatic research interests include: checkpoint inhibitor immunotherapy, adoptive cellular immunotherapies, preclinical models of immunotherapy, canine immunotherapy, synthetic biology, nanotechnology, and combination cancer therapies.

Email